PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bionaria, 11Bis Rue de la Garenne, 69290 Saint-Genis-les-Ollières, France. Electronic address: afluckiger@vbivaccines.com.\', \'VBI Vaccines, 201-310 Hunt Club Road, Ottawa, ON K1V 1C1, Canada.\', \'National Research Council Canada, Department of Human Health Therapeutics, 100 Sussex Drive, Ottawa, ON K1A0R6, Canada.\', \'Vaccine and Infectious Disease Organization-International Vaccine Centre, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Saskatchewan S7N 5E3 Canada.\', \'VBI Vaccines, Cambridge, 222 Third Street, Cambridge 02142, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)00911-710.1016/j.vaccine.2021.07.034
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34304928
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34304928>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34304928>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all